Back to Previous Page

Irritable Bowel Syndrome

(Functional Colitis; IBS; Intestinal Neurosis; Irritable Colon; Laxative Colitis; Mucous Colitis; Nervous Indigestion; Spastic Colon)

Definition

Irritable bowel syndrome (IBS) is a chronic disorder of the intestines. IBS does not cause inflammation and does not lead to a more serious condition.

Causes

The cause is unknown. With IBS, the muscles in the colon do not work normally and may spasm. If you have IBS, your colon may be more sensitive, reacting strongly to food and medication. Food allergies and certain bacteria may add to the symptoms. IBS may also occur after having the stomach flu (called gastroenteritis).

Risk Factors

These factors increase your chance of developing IBS:
  • Sex: female
  • Family members with IBS
  • Age: typically begins in young adulthood
  • Stress
  • Generalized anxiety disorder (associated with IBS)
  • Abuse (may be associated with IBS)
Tell your doctor if you have any of these risk factors.

Symptoms

Symptoms usually come and go, and range from mild to severe. They include:
  • Abdominal cramps
  • Gas and bloating
  • Pain that resolves with a bowel movement
  • Loose stools
  • Diarrhea
  • Constipation
  • Alternating diarrhea and constipation
  • Urge to move bowels again immediately following a bowel movement
  • Mucus in the stool
These factors may worsen your symptoms:
  • Stress
  • Menstrual periods
  • Large meals or fatty foods
  • Excess gas

Diagnosis

The doctor will ask about your symptoms and medical history, and perform a physical exam. In many cases, a diagnosis can be made based on this. Since there is no diagnostic test for IBS, doctors have created criteria for making a diagnosis.
Your doctor may order the following tests to rule out other conditions:
  • Analysis of a stool sample to check for blood or evidence of inflammation
  • Blood tests
  • Barium enema—injection of fluid into the rectum to make the colon show up on an x-ray, allows the doctor to see abnormal spots in the colon
  • Flexible sigmoidoscopy—a thin, lighted tube inserted into the rectum to examine the rectum and the lower colon
  • Colonoscopy—a thin, lighted tube inserted through the rectum and into the colon to examine the lining of the entire colon
Your doctor may also screen you for celiac disease, which is more common in people with IBS.
Colonoscopy
Colonoscopy scope
Copyright © Nucleus Medical Media, Inc.

Treatment

There is no cure for IBS. Treatment focuses on controlling symptoms.

Diet

The following changes to your diet may help control symptoms:
  • Keep a food diary of what you eat and how your body responds. Share this with your doctor. You may have a food allergy.
  • Make gradual changes to your diet. Record the results.
  • Avoid foods that have caused problems in the past. A dietitian can help you substitute foods.
  • Avoid foods and drinks that may cause symptoms:
    • High fat foods, spicy foods
    • Dairy products
    • Onions, cabbage, and other gas-producing food
    • Large amounts of alcohol or caffeine
  • Eat foods that may reduce the chance of spasm, such as:
  • Eat smaller meals more often or smaller portions.
  • Eat slowly and try not to swallow air.
  • Drink plenty of water. This will help to reduce constipation.

Exercise

Participating in a regular exercise program can help improve bowel function and other IBS symptoms. If you would like to start exercising, check with your doctor to make sure you are healthy enough.

Stress Management

Talk to your doctor about ways to reduce stress, such as:

Education

Learn as much as you can about IBS and ways that you can reduce your symptoms. You may also find it helpful to join a support group.

Medication

Depending on your symptoms, your doctor may recommend:
  • Antispasmodic agent (such as dicyclomine, alverine citrate)
  • Antibiotics (rifaximin [Xifaxan])
  • High-fiber bulking agent (psyllium )
  • Antiflatulent (simethicone )
  • Antidiarrheal agent (loperamide )
  • Low-dose antidepressant
  • Pain reliever (acetaminophen)—may help with crampy abdominal pain
  • Serotonin receptor agonists and antagonists (also called 5-HT3 antagonists)—may be helpful for treating diarrhea, as well as treating other IBS symptoms, like abdominal pain in women (alosetron)
  • Probiotics ("friendly" bacteria)—may be helpful, but talk to your doctor before taking
  • Peppermint oil
In some cases, your doctor may recommend that you take a combination of medicines.

Prevention

There are no guidelines for preventing IBS because the cause is unknown.

RESOURCES

American College of Gastroenterology http://gi.org

American Gastroenterological Association http://www.gastro.org

Irritable Bowel Syndrome Association http://www.ibsgroup.org

CANADIAN RESOURCES

Health Canada http://www.hc-sc.gc.ca

Irritable Bowel Syndrome Association http://www.ibsgroup.org

References

Acidophilus and other probiotics. EBSCO Natural and Alternative Treatments website. Available at: http://www.ebscohost.com/healthLibrary/. Updated June 2008. Accessed July 15, 2008.

Conn HF, Rakel RE. Conn's Current Therapy. Philadelphia, PA: WB Saunders Co; 2001.

Drossman DA. Treatment for bacterial overgrowth in the irritable bowel syndrome. Ann Intern Med . 2006;145:626-628.

Griffith HW. Griffith's 5-Minute Clinical Consult. Baltimore, MD: Lippincott Williams Wilkins; 1999.

Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritable bowel syndrome—a meta-analysis. Am J Gastroenterol. 2006;101:1894-1899.

Irritable bowel syndrome. American Society of Colon and Rectal Surgeons website. Available at: http://www.fascrs.org/. Update October 2007. Accessed July 15, 2008.

Irritable bowel syndrome. EBSCO DynaMed website. Available at: https://dynamed.ebscohost.com/about/about-us. Updated December 2008. Accessed January 6, 2009.

Irritable bowel syndrome (IBS). EBSCO Health Library website. Available at: http://www.ebscohost.com/healthLibrary/. Updated July 2008. Accessed July 7, 2008.

Irritable bowel syndrome. National Institute of Diabetes and Digestive and Kidney Diseases website. Available at: http://www.niddk.nih.gov/ Update September 2007. Accessed July 15, 2008.

Murch S. Allergy and intestinal dysmotility—evidence of genuine causal linkage? Curr Opin Gastroenterol . 2006;22:664-668.

Rubin G, De Wit N, Meineche-Schmidt V, Seifert B, Hall N, Hungin P. The diagnosis of IBS in primary care: consensus development using nominal group technique. Family Practitioner. 2006;23:687-692.

Sleisenger MH, Fordtran JS, Feldman M, Scharschmidt B. Sleisenger Fordtran's Gastrointestinal and Liver Disease. 6th ed. Philadelphia, PA: WB Saunders Co; 1998.

Talley NJ, Boyce PM, Jones M. Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study. Gut.1998;42: 47-53.

Yan F, Polk DB. Probiotics as functional food in the treatment of diarrhea. Current Opinion in Clinical Nutrition and Metabolic Care. 2006;9:717-721.

9/26/2006 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Mueller-Lissner S, Tytgat GN, Paulo LG, et al. Placebo-and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Alimentary Pharmacology and Therapeutics . 2006;23:1741-1748.

4/10/2007 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : US Food and Drug Administration. FDA announces discontinued marketing of GI drug, Zelnorm, for safety reasons [press release]. March 30, 2007. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108879.htm.

1/6/2009 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ . 2008;337:a2313.

10/9/2009 DynaMed Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Lee S, Wu J, Ma YL, Tsang A, Guo WJ, Sung J. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009;30(6):643.

11/4/2009 DynaMed Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol. 2009;104(7):1831-1843.

1/11/2010 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Wittmann T, Paradowski L, Ducrotté P, Bueno L, Andro Delestrain MC. Clinical trial: efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome: results of a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2009 Dec 10. [Epub ahead of print]

7/16/2010 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Dorn SD. Systematic review: self-management support interventions for irritable bowel syndrome. Aliment Pharmacol Ther. 2010 May 22. [Epub ahead of print]

1/14/2011 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32.

4/22/2011 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Johannesson E, Simrén M, Strid H, Bajor A, Sadik R. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2011 Jan 4. [Epub ahead of print]

Revision Information

  • Reviewer: Daus Mahnke, MD
  • Review Date: 09/2012 -
  • Update Date: 00/93/2012 -

This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.

Copyright © EBSCO Publishing
All rights reserved.